Skip to main navigation Skip to search Skip to main content

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study

  • Pietro Lampertico
  • , Maria Buti
  • , Scott Fung
  • , Sang Hoon Ahn
  • , Wan Long Chuang
  • , Won Young Tak
  • , Alnoor Ramji
  • , Chi Yi Chen
  • , Edward Tam
  • , Ho Bae
  • , Xiaoli Ma
  • , John F. Flaherty
  • , Anuj Gaggar
  • , Audrey Lau
  • , Yang Liu
  • , George Wu
  • , Vithika Suri
  • , Susanna K. Tan
  • , G. Mani Subramanian
  • , Huy Trinh
    • Seung Kew Yoon, Kosh Agarwal, Young Suk Lim, Henry L.Y. Chan
  • University of Milan
  • Hospital Vall d'Hebron
  • Toronto General Hospital
  • Yonsei University
  • Kaohsiung Medical University
  • Kyungpook National University
  • Gastrointestinal Research Institute
  • Chia-Yi Christian Hospital
  • LAIR Centre
  • Asian Pacific Liver Center
  • Hahnemann University Hospital
  • Gilead Sciences, Inc.
  • Silicon Valley Research Institute
  • King's College Hospital
  • University of Ulsan
  • Chinese University of Hong Kong

Research output: Contribution to journal › Article › peer-review

148 Scopus citations

Fingerprint

Dive into the research topics of 'Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in virologically suppressed patients with chronic hepatitis B: a randomised, double-blind, phase 3, multicentre non-inferiority study'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science